Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Depreciation & Amortization (CF) (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Depreciation & Amortization (CF) for 2 consecutive years, with $4000.0 as the latest value for Q4 2023.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 99.41% to $4000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $15000.0, a 99.36% decrease, with the full-year FY2024 number at $58000.0, up 286.67% from a year prior.
  • Depreciation & Amortization (CF) was $4000.0 for Q4 2023 at LENZ Therapeutics, roughly flat from $4000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $682000.0 in Q4 2022 to a low of $3000.0 in Q1 2023.